Earnings Feed
Start Free
Home/Filings/4/0001104659-12-023615
4//SEC Filing

ODINK DEBRA 4

Accession 0001104659-12-023615

CIK 0001316175other
View on SEC.govCompany Profile

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 4:25 PM ET

Size

6.7 KB

Accession

0001104659-12-023615

Insider Transaction Report

Form 4
Period: 2012-03-30
Anthera Pharmaceuticals IncANTH
ODINK DEBRA
VP, Pharmaceutical R&D
Transactions
  • Award

    Stock Option (right to buy)

    2012-03-30+160,000→ 160,000 total
    Exercise: $2.21Exp: 2022-03-30→ Common Stock (160,000 underlying)
Holdings

  • Common Stock

    26,659

  • Common Stock

    (indirect: By Trust)
    95,928
Footnotes (1)
  • [F1]The Stock Option vests and becomes exercisable pro-rata monthly beginning January 3, 2012 (the "Vesting Start Date"). This Stock Option is completely vested on the fourth anniversary of the Vesting Start Date.

Documents

1 file

Issuer

Anthera Pharmaceuticals Inc

CIK 0001316175

→
Entity typeother

Related Parties

1
  • filerCIK 0001281719

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:25 PM ET
Size
6.7 KB
View on SEC.gov